Meta-analysis exploring the effect of oncogenic driver mutations on outcome of metastatic non-small cell lung cancer (mNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICI) or docetaxel (doc).
2018 ◽
Vol 36
(15_suppl)
◽
pp. 9029-9029
2020 ◽
Vol 21
(2)
◽
pp. 106-113.e5
◽
2017 ◽
Vol 12
(11)
◽
pp. S2150
◽